These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 31603917

  • 1. A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas.
    van der Meeren LE, Kluiver J, Rutgers B, Alsagoor Y, Kluin PM, van den Berg A, Visser L.
    PLoS One; 2019; 14(10):e0223260. PubMed ID: 31603917
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group.
    Staiger AM, Ziepert M, Horn H, Scott DW, Barth TFE, Bernd HW, Feller AC, Klapper W, Szczepanowski M, Hummel M, Stein H, Lenze D, Hansmann ML, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G, German High-Grade Lymphoma Study Group.
    J Clin Oncol; 2017 Aug 01; 35(22):2515-2526. PubMed ID: 28525305
    [Abstract] [Full Text] [Related]

  • 4. Clinical Significance of BCL2, C-MYC, and BCL6 Genetic Abnormalities, Epstein-Barr Virus Infection, CD5 Protein Expression, Germinal Center B Cell/Non-Germinal Center B-Cell Subtypes, Co-expression of MYC/BCL2 Proteins and Co-expression of MYC/BCL2/BCL6 Proteins in Diffuse Large B-Cell Lymphoma: A Clinical and Pathological Correlation Study of 120 Patients.
    Ting CY, Chang KM, Kuan JW, Sathar J, Chew LP, Wong OJ, Yusuf Y, Wong L, Samsudin AT, Pana MNBM, Lee SK, Gopal NSR, Puri R, Ong TC, Bahari SK, Goh AS, Teoh CS.
    Int J Med Sci; 2019 Aug 01; 16(4):556-566. PubMed ID: 31171907
    [Abstract] [Full Text] [Related]

  • 5. Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm.
    Yoon N, Ahn S, Yong Yoo H, Jin Kim S, Seog Kim W, Hyeh Ko Y.
    Oncotarget; 2017 Mar 28; 8(13):22014-22022. PubMed ID: 28423544
    [Abstract] [Full Text] [Related]

  • 6. An immunohistochemical study of diffuse large B-cell lymphoma with molecular subtyping based on Hans algorithm.
    Ananthamurthy A, Murali M.
    Indian J Pathol Microbiol; 2024 Jul 01; 67(3):564-568. PubMed ID: 38394429
    [Abstract] [Full Text] [Related]

  • 7. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL, Liu YH, Zhuang HG, Li L, Xu FP, Zhang F, Luo XL, Xu J.
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr 01; 40(4):235-9. PubMed ID: 21615996
    [Abstract] [Full Text] [Related]

  • 8. Germinal center B-cell-like versus non-germinal center B-cell-like as important prognostic factor for localized nodal DLBCL.
    Habara T, Sato Y, Takata K, Iwaki N, Okumura H, Sonobe H, Tanaka T, Orita Y, Abd Al-Kader L, Asano N, Ennishi D, Yoshino T.
    J Clin Exp Hematop; 2012 Apr 01; 52(2):91-9. PubMed ID: 23037624
    [Abstract] [Full Text] [Related]

  • 9. [Prevalence of germinal center B-cell-like and non-germinal center B-cell-like types of diffuse large B-cell lymphoma in Shanghai, China].
    Chen Y, Chen H, Fu K, Zhu XZ, Irons R.
    Zhonghua Bing Li Xue Za Zhi; 2010 May 01; 39(5):313-8. PubMed ID: 20654154
    [Abstract] [Full Text] [Related]

  • 10. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
    Ye ZY, Cao YB, Lin TY, Lin HL.
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct 01; 36(10):654-9. PubMed ID: 18194597
    [Abstract] [Full Text] [Related]

  • 11. Primary diffuse large B-cell lymphoma of the oral cavity: germinal center classification.
    Bhattacharyya I, Chehal HK, Cohen DM, Al-Quran SZ.
    Head Neck Pathol; 2010 Sep 01; 4(3):181-91. PubMed ID: 20533006
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients.
    Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, Zhang F, Li HM.
    Hum Pathol; 2008 Jun 01; 39(6):875-84. PubMed ID: 18440593
    [Abstract] [Full Text] [Related]

  • 13. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
    Brown PJ, Wong KK, Felce SL, Lyne L, Spearman H, Soilleux EJ, Pedersen LM, Møller MB, Green TM, Gascoyne DM, Banham AH.
    Leukemia; 2016 Mar 01; 30(3):605-16. PubMed ID: 26500140
    [Abstract] [Full Text] [Related]

  • 14. Comparison of protein-based cell-of-origin classification to the Lymph2Cx RNA assay in a cohort of diffuse large B-cell lymphomas in Malaysia.
    Phang KC, Akhter A, Tizen NMS, Rahman FA, Zahratul Azma R, Elyamany G, Shabani-Rad MT, Masir N, Mansoor A.
    J Clin Pathol; 2018 Mar 01; 71(3):215-220. PubMed ID: 28775174
    [Abstract] [Full Text] [Related]

  • 15. Diffuse large B-cell lymphoma.
    Li S, Young KH, Medeiros LJ.
    Pathology; 2018 Jan 01; 50(1):74-87. PubMed ID: 29167021
    [Abstract] [Full Text] [Related]

  • 16. Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.
    Costa LJ, Feldman AL, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Ansell SM.
    Br J Haematol; 2008 Jul 01; 142(3):404-12. PubMed ID: 18492096
    [Abstract] [Full Text] [Related]

  • 17. Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population.
    Chen W, Wang H, Chen H, Liu S, Lu H, Kong D, Huang X, Kong Q, Lu Z.
    Eur J Haematol; 2014 Jul 01; 92(5):407-12. PubMed ID: 24400911
    [Abstract] [Full Text] [Related]

  • 18. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M, Zhao H, Xu W, Bao S, Cheng L, Sun J.
    Mol Cancer; 2017 Jan 19; 16(1):16. PubMed ID: 28103885
    [Abstract] [Full Text] [Related]

  • 19. Microarray-based classification of diffuse large B-cell lymphoma.
    Poulsen CB, Borup R, Nielsen FC, Borregaard N, Hansen M, Grønbaek K, Møller MB, Ralfkiaer E.
    Eur J Haematol; 2005 Jun 19; 74(6):453-65. PubMed ID: 15876249
    [Abstract] [Full Text] [Related]

  • 20. Impact of Double Expression of C-MYC/BCL2 Protein and Cell of Origin Subtypes on the Outcome among Patients with Diffuse Large B-Cell Lymphoma: a Single Asian Center Experience.
    Teoh CS, Lee SY, Chiang SK, Chew TK, Goh AS.
    Asian Pac J Cancer Prev; 2018 May 26; 19(5):1229-1236. PubMed ID: 29801406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.